Financial & Business News
LATEST INVESTING HEADLINES
TORONTO, ON / ACCESSWIRE / November 26, 2024 / Toggle3D.ai (the "Company") (CSE:TGGL)(OTCQB:TGGLF)(FSE:Q0C), the creator of FOTOgpt.ai, a leading AI-powered photography studio, is excited to announce its strategic integration with ARway.ai's ("ARway" or the "Company") (CSE:ARWY),(OTCQB:ARWYF)(FSE:E65), Map Dynamics (MapD) platform. This partnership brings FOTOgpt.ai's cutting-edge AI photography tools to MapD's extensive network of over 400 enterprise clients, creating new revenue opportunities and expanding the capabilities of both platforms.
Although November is nearly over, plenty of stocks still look like great buys right now. Three that I've got my eye on are ASML (ASML 1.72%), Meta Platforms (META 1.07%), and Alphabet (GOOG 1.72%) (GOOGL 1.75%).
NEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
NEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Celsius Holdings, Inc. ("Celsius" or "the Company") (NASDAQ:CELH) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Celsius securities between February 29, 2024 and September 04, 2024 inclusive (the "Class Period").
NEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Iris Energy Limited ("Iris Energy" or "the Company") (NASDAQ:IREN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Iris Energy securities between June 20, 2023, and July 11, 2024, inclusive (the "Class Period").
CHATHAM, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, announced today that Jessica Morris, Chief Operating Officer of Tonix Pharmaceuticals, will present and conduct investor meetings at NobleCon20, Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference, being held December 3-4 in Boca Raton, Fla.
NEW YORK, NY / ACCESSWIRE / November 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mynaric AG ("Mynaric" or "the Company") (NASDAQ:MYNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Mynaric securities between June 20, 2024, and October 7, 2024, inclusive (the "Class Period").
CAMBRIDGE, Mass. , Nov. 26, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E.
NEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Humacyte, Inc. ("Humacyte" or "the Company") (NASDAQ:HUMA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Humacyte securities between May 10, 2024 and October 17, 2024 inclusive (the "Class Period").
NEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Elanco securities between November 7, 2023, and June 26, 2024, inclusive (the "Class Period").